ARVINAS ($ARVN) posted quarterly earnings results for Q4 2025 on Tuesday, February 24th. The company reported earnings of -$1.10 per share, missing estimates of -$0.60 by $0.50. The company also reported revenue of $9,500,000, missing estimates of $35,576,814 by $-26,076,814.
You can see Quiver Quantitative's $ARVN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ARVINAS Insider Trading Activity
ARVINAS insiders have traded $ARVN stock on the open market 7 times in the past 6 months. Of those trades, 1 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $ARVN stock by insiders over the last 6 months:
- BRIGGS MORRISON purchased 30,000 shares for an estimated $227,010
- NOAH BERKOWITZ (Chief Medical Officer) sold 5,685 shares for an estimated $67,594
- ANDREW SAIK (Chief Financial Officer) sold 5,134 shares for an estimated $61,043
- ANGELA M CACACE (Chief Scientific Officer) sold 4,592 shares for an estimated $54,598
- RANDY TEEL (President and CEO) sold 4,403 shares for an estimated $52,351
- DAVID K LOOMIS (Chief Accounting Officer) has made 0 purchases and 2 sales selling 1,246 shares for an estimated $14,354.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ARVINAS Hedge Fund Activity
We have seen 99 institutional investors add shares of ARVINAS stock to their portfolio, and 136 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- LOGOS GLOBAL MANAGEMENT LP removed 5,575,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $66,119,500
- POINT72 ASSET MANAGEMENT, L.P. added 2,315,361 shares (+inf%) to their portfolio in Q4 2025, for an estimated $27,460,181
- CAPTION MANAGEMENT, LLC removed 1,343,029 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $11,442,607
- VANGUARD GROUP INC removed 1,331,629 shares (-15.6%) from their portfolio in Q4 2025, for an estimated $15,793,119
- TCG CROSSOVER MANAGEMENT, LLC added 1,048,851 shares (+64.8%) to their portfolio in Q4 2025, for an estimated $12,439,372
- TWO SIGMA INVESTMENTS, LP added 992,463 shares (+inf%) to their portfolio in Q4 2025, for an estimated $11,770,611
- OPALEYE MANAGEMENT INC. removed 987,818 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $11,715,521
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ARVINAS Analyst Ratings
Wall Street analysts have issued reports on $ARVN in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stephens & Co. issued a "Overweight" rating on 11/10/2025
- BTIG issued a "Buy" rating on 09/18/2025
To track analyst ratings and price targets for ARVINAS, check out Quiver Quantitative's $ARVN forecast page.
ARVINAS Price Targets
Multiple analysts have issued price targets for $ARVN recently. We have seen 6 analysts offer price targets for $ARVN in the last 6 months, with a median target of $15.0.
Here are some recent targets:
- Yigal Nochomovitz from Citigroup set a target price of $15.0 on 01/06/2026
- Etzer Darout from Barclays set a target price of $18.0 on 12/17/2025
- Sudan Loganathan from Stephens & Co. set a target price of $15.0 on 11/10/2025
- Derek Archila from Wells Fargo set a target price of $15.0 on 11/06/2025
- Jeet Mukherjee from BTIG set a target price of $14.0 on 10/30/2025
- Paul Choi from Goldman Sachs set a target price of $6.0 on 10/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
